<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="29662">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02720549</url>
  </required_header>
  <id_info>
    <org_study_id>4-2015-1198</org_study_id>
    <nct_id>NCT02720549</nct_id>
  </id_info>
  <brief_title>The Effect of Remote Ischemic Postconditioning on Postoperative Renal Dysfunction in Patients Undergoing Valvular Heart Surgery</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ischemic reperfusion injury of cardiopulmonary bypass and postoperative renal dysfunction is
      a common problem which influence poor outcome in subjects undergoing valvular heart surgery.
      The incidence of postoperative renal dysfunction was reported as high as 7~8% in heart
      surgery using bypass, and is thought to be caused by ischemia/reperfusion injury. Remote
      ischemic postconditioning was also reported to be protective for ischemic/reperfusion injury
      in previous animal studies and stoke patients. Therefore, the investigators are trying to
      evaluate the clinical effect of remote ischemic postconditioning on postoperative renal
      dysfunction in subjects undergoing valvular heart surgery with bypass.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2016</start_date>
  <completion_date type="Anticipated">February 2018</completion_date>
  <primary_completion_date type="Anticipated">January 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double Blind (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>incidence of postoperative renal dysfunction using AKIN(acute kidney injury network) criteria</measure>
    <time_frame>5 days</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">252</enrollment>
  <condition>Valvular Heart Disease Patients</condition>
  <arm_group>
    <arm_group_label>post-ischemic conditioning group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>valvular surgery with bypass group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>remote ischemic postconditioning</intervention_name>
    <description>Remote ischemic postconditioning post group will take a remote ischemic postconditioning with tourniquet in their lower extremity under thigh. The conditioning is 5 minutes of inflation, and 5 minutes of deflation, repeated 3 cycles.</description>
    <arm_group_label>post-ischemic conditioning group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>valvular surgery with bypass</intervention_name>
    <description>valvular surgery with bypass</description>
    <arm_group_label>valvular surgery with bypass group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients who are undergoing valvular heart surgery

          -  Adult

          -  age 19-80

        Exclusion Criteria:

          -  peripheral vascular disease with circulation deterioration

          -  Renal replacement therapy

          -  preconditioning medication

          -  Myocardiac infarction within 3 weeks

          -  active infective endocarditis

          -  high dosage steroid therapy

          -  mental retardation

          -  unlettered person
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Anesthesiology and Pain Medicine and Anesthesia</name>
      <address>
        <city>Seoul</city>
        <zip>120-752</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Young Lan Kwak, MD</last_name>
      <phone>82-2-2228-8513</phone>
      <email>ylkwak@yuhs.ac</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <lastchanged_date>March 26, 2016</lastchanged_date>
  <firstreceived_date>March 22, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Heart Valve Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
